Aiosyn develops smart software that helps pathologists diagnose faster and more accurately.
Smart software aids pathologists
The better the diagnosis, the better the patient can be helped. The number of cancer patients in the Netherlands is expected to increase by 70% by 2032. At the same time, there is a shortage of pathologists, leading to increased work pressure. Aiosyn's smart software, based on artificial intelligence, helps pathologists work more efficiently and effectively. The name Aiosyn is derived from 'artificial intelligence' and eosin, the most commonly used dye for pathology slides. Aiosyn is a spin-out from the Radboud University Medical Center.
Aiosyn is located in Nijmegen.
Founders: Patrick de Boer, Jeroen van der Laak, Wouter Bulten, David Tellez
Website: https://www.aiosyn.com/
LinkedIn: https://www.linkedin.com/company/aiosyn/
